ChinaAdd to My Companies | Give a Referral for this Company | Print this Profile
Partnership and licensing opportunities from Innovent Biologics.
Built with an innovation mindset, Innovent has established a product pipeline targeting therapeutic areas including oncology, ophthalmology, autoimmune diseases, and cardiovascular diseases. In the nine years since its founding, Innovent Biologics has entered into strategic collaborations with multiple prestigious corporations and research institutes in China and around the world. The Multiple strategic cooperation agreements entered into by Innovent and Eli Lilly, with over US$2.5Bn of economic interest involved, have set records for deals between Chinese players and MNCs.
This is the Partnership and Licensing section of the company profile page for Innovent Biologics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.